InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.04
(
-0.19%
)
US TECH 100
19,415.64
(
0.00%
)
Dow Jones
41,965.39
(
-0.58%
)
Brent Oil
72.83
(
-2.32%
)
Bitcoin
63,148.60
(
-1.74%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 84
Posts 12534
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: Jesspro post# 79326

Monday, 12/05/2016 8:27:42 AM

Monday, December 05, 2016 8:27:42 AM

Post# of 80490
"It's not influencing the FDA. It's convincing them based on the updated data if it's for the benefit of the suffering patients. This is a fact why some drugs are approved early,some are not, and some delayed. Ariad may have the confidence based on the data they have seen...jmo"

Jess, it doesn't work that way with the FDA. FDA only reviews the documents in the NDA submission. They do not take in consideration a "convincing" document/ discussion at a hematological conference....
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up